Oncology Stocks
AZN$46.31-0.04 (-0.09%)
NVS$53.380.04 (0.07%)
SNY$32.91-0.05 (-0.15%)
GSK$45.280.14 (0.31%)

Latest Clinical News

Zevalin® Confirmed Effective for Patients with Follicular Lymphoma Who Have Failed an Autologous Transplant (9/5/2008)
Researchers from France have reported that five of eight patients with follicular lymphoma who had failed an autologous stem cell transplant achieved a complete remission with standard doses of Zevalin® (Yttrium-90 ((90)Y) ibritumomab tiuxetan). The details of this study appeared in an early online publication in Leukemia-Lymphoma of July 15, 2008.

Forty Percent of Postmenopausal Breast Cancers Preventable by Lifestyle Changes (9/5/2008)
Researchers from the University of Wisconsin-Madison, the H. Lee Moffitt Cancer Center, Dartmouth Medical School, and the Fred Hutchinson Cancer Center have reported that 40.7% of postmenopausal breast cancer can be prevented by changes in lifestyle. The details of this study appeared in the August 15, 2008 issue of the American Journal of Epidemiology.

Subscribe to be informed of the latest cancer news.

Featured Conference Coverage

A Report from the 2008 Meeting of the American Society of Clinical Oncology

Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia

Highlights of Treatment of Hematological Malignancies

Breast Cancer Update

The Evolving Role of EGFR Inhibitors in Colorectal Cancer


A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists

Updates in the Management of Gynecologic Cancers

A report from the 2008 ASCO Genitourinary Cancers Symposium

Updates in the Management of Prostate and Kidney Cancers - CME

Latest FDA News

© 1998-2007 OncoEd, Inc.   All Rights Reserved.